10x Genomics (TXG) Net Cash Flow Growth (3y) (2021 - 2026)
10x Genomics (TXG) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.67 Bn | 24.36 Bn | 662.02 Mn | 31.95% |
| 2 | BrightSpring Health Services | 14.61 Bn | 13.71 Bn | 482.22 Mn | 590.29% |
| 3 | Healthequity | 8.30 Bn | 8.03 Bn | 256.31 Mn | -23.22% |
| 4 | Hinge Health | 5.92 Bn | 5.60 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.84 Bn | 5.30 Bn | 106.18 Mn | -47.37% |
| 6 | MiniMed | 4.48 Bn | 4.18 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.44 Bn | 4.38 Bn | 216.84 Mn | - |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | 92.69% |
| 9 | Privia Health | 3.17 Bn | 2.76 Bn | - | -17.84% |
| 10 | Omnicell | 1.85 Bn | 1.61 Bn | 140.36 Mn | 139.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.37% |
| Dec 31, 2025 | 69.30% |
| Sep 30, 2025 | 42.15% |
| Jun 30, 2025 | 36.30% |
| Mar 31, 2025 | 28.45% |
| Dec 31, 2024 | -60.95% |
| Sep 30, 2024 | 34.94% |
| Jun 30, 2024 | 71.77% |
| Mar 31, 2024 | 57.46% |
| Dec 31, 2023 | 32.14% |
| Sep 30, 2023 | -26.77% |
| Jun 30, 2023 | 31.94% |
| Mar 31, 2023 | 65.43% |
| Dec 31, 2022 | -144.54% |
| Sep 30, 2022 | -27.98% |
| Jun 30, 2022 | -56.64% |
| Mar 31, 2022 | -582.37% |
| Dec 31, 2021 | 10.40% |